氟立班丝氨结构式
|
常用名 | 氟立班丝氨 | 英文名 | Flibanserin |
---|---|---|---|---|
CAS号 | 167933-07-5 | 分子量 | 390.40200 | |
密度 | 1.292 g/cm3 | 沸点 | N/A | |
分子式 | C20H21F3N4O | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | N/A | |
符号 |
GHS06 |
信号词 | Danger |
氟立班丝氨用途Flibanserin是一种新型的多功能性五羟色胺受体激动剂和拮抗剂 (MSAA)。 |
中文名 | 氟立班丝氨 |
---|---|
英文名 | Flibanserin |
中文别名 | 氟班色林 | 3-[2-[4-[4-(三氟甲基)苯基]哌嗪-1-基]乙基]-1H-苯并咪唑-2-酮 |
英文别名 | 更多 |
密度 | 1.292 g/cm3 |
---|---|
分子式 | C20H21F3N4O |
分子量 | 390.40200 |
精确质量 | 390.16700 |
PSA | 44.27000 |
LogP | 3.17350 |
外观性状 | white to beige |
折射率 | 1.566 |
储存条件 | 2-8°C |
水溶解性 | DMSO: soluble10mg/mL, clear |
符号 |
GHS06 |
---|---|
信号词 | Danger |
危害声明 | H301-H315-H319-H335 |
警示性声明 | P261-P301 + P310-P305 + P351 + P338 |
危害码 (欧洲) | T |
风险声明 (欧洲) | 25-36/37/38 |
安全声明 (欧洲) | 26-45 |
危险品运输编码 | UN 2811 6.1 / PGIII |
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
J. Sex. Med. 8(11) , 3160-72, (2011) Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that has been shown to increase sexual desire and reduce distress in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD).To assess t... |
|
Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
J. Sex. Med. 9(12) , 3180-8, (2012) Hypoactive Sexual Desire Disorder (HSDD) is a common form of Female Sexual Dysfunction characterized by low sexual desire that causes distress or interpersonal difficulty.This 52-week open-label exten... |
|
Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
J. Sex. Med. 8(12) , 3262-70, (2011) Assessing the sexual response in women with female sexual dysfunctions (FSDs) in clinical trials remains difficult. Part of the challenge is the development of meaningful and valid end points that cap... |
Ectris |
1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one |
Addyi |
BIMT-17 |
Bimt 17 |
2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]- |
BIMT-17-BS |
Flibanserin |
3-[2-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one |
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one |
1-(2-{4-[3-(Trifluoromethyl)phenyl]-1-piperazinyl}ethyl)-1,3-dihydro-2H-benzimidazol-2-one |
1-(2-{4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-1,3-dihydro-2H-benzimidazol-2-one |